-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On June 22, Baiyunshan announced that its subsidiary Tianxin Pharmaceutical's cefuroxime sodium for injection has passed the consistency evaluation of generic drugs
Cefuroxime sodium for injection (Xinfuxin) is suitable for the treatment and prevention of infections caused by sensitive strains of specific microorganisms in the following diseases: respiratory tract infections, ear, nose and throat infections, urinary tract infections, skin and soft tissue infections, sepsis, meningitis, gonorrhea, Bone and joint infections, puerperium and gynecological infections
According to public information, the domestic manufacturers of cefuroxime sodium for injection that have passed or deemed to have passed the consistency evaluation include Zhejiang Huidisen Pharmaceutical Co.
As of the date of this announcement, Tianxin Pharmaceutical has invested approximately RMB 4.